Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Is It Time to Take MRD More Seriously? Relationship between MRD, Functional Cure and Life Expectancy Among Patients with Ph- B Cell Precursor ALL (BCP-ALL)

Qiujun Shao, Simran Tiwana, Nicholas Despiegel, Franziska Dirnberger

Blood (2019) 134 (Supplement_1): 5814.

https://doi.org/10.1182/blood-2019-126309

Published: 2019

Journal Articles

Nutrition Access in Adult Sickle Cell Patients: An Exploratory Study

Sarah Agamah, MBA, MPH

Blood (2019) 134 (Supplement_1): 3472.

https://doi.org/10.1182/blood-2019-130505

Published: 2019

Journal Articles

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Raven Myrick, MSN, CRNP, Brandi Pernell, DNP, Avi Madan-Swain, PhD, Thomas H. Howard, MD, Lee Hilliard, MD, Jeffrey D. Lebensburger, DO, MSPH

Blood (2019) 134 (Supplement_1): 4691.

https://doi.org/10.1182/blood-2019-131059

Published: 2019

Journal Articles

Comparison of Health Outcomes in Adolescent and Young Adults (AYA) Oncology Patients Treated at a Pediatric Versus Adult Institute

Amy Moskop, MD, Ke Yan, PhD, Sarah K. Dobrozsi, MD, Julie Panepinto, MDMSPH

Blood (2019) 134 (Supplement_1): 4743.

https://doi.org/10.1182/blood-2019-121616

Published: 2019

Journal Articles

Clonal Hematopoiesis in Older Women with Extremely Skewed, Non-Random X-Inactivation Is Associated with Previous Cardiovascular and Cerebrovascular Events

Emily Marre, MPH, Julia Erin Wiedmeier, MD MPH, Zhenzhen Zhang, PhD, Hyunjung Lee, Dana Parker, Kelsey Westerlund, Christopher A. Eide, Catherine Kato, Maros Ferencik, MD PhD, Brian J. Druker, MD, Kim-Hien Dao, DO, PhD

Blood (2018) 132 (Supplement 1): 2574.

https://doi.org/10.1182/blood-2018-99-120323

Published: 2018

Journal Articles

CAR-T Therapy Displays Favorable Gains in Health Outcomes and Competitive Cost-Effectiveness When Compared with Past Innovative Cancer Treatments

James Baumgardner, PhD, Katie Everson, MS, Michelle Brauer, BS, Jie Zhang, PhD, Yanni Hao, PhD, Jamae Liu, PhD, Darius N Lakdawalla, PhD

Blood (2018) 132 (Supplement 1): 322.

https://doi.org/10.1182/blood-2018-99-116763

Published: 2018

Journal Articles

Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada

Haowei Linda Sun, MD FRCPC, Ming Yang, PhD, Man-Chiu Poon, MD, Adrienne Lee, MD, Katherine Sue Robinson, MD, Michelle Sholzberg, MDM, MSc, FRCPC, John K. Wu, MBBS, FRCPC, MS, Alfonso Iorio, MD PhD, Victor S. Blanchette, FRCP, Robert J Klaassen, MD FRCPC, Shannon Jackson, MD FRCPC

Blood (2018) 132 (Supplement 1): 4813.

https://doi.org/10.1182/blood-2018-99-113858

Published: 2018

Journal Articles

Mortality Among California's Sickle Cell Data Collection Cohort, 2005-2015

Susan T Paulukonis, MA, MPH, Robert Ward Hagar, MD

Blood (2017) 130 (Supplement 1): 2133.

https://doi.org/10.1182/blood.V130.Suppl_1.2133.2133

Published: 2017

Journal Articles

Health-Related Quality of Life (HRQL) Among Hospitalized Adults with Sickle Cell Disease (SCD): Incorporating Patient-Reported Outcome (PRO) Measures in Clinical Care

Kimberly S Esham, MD, Angie Mae Rodday, PhD MS, Ruth Ann Weidner, MBA, MRP, Rachel J. Buchsbaum, MD, Hedy P Smith, MD PhD, Susan K Parsons, MDMRP

Blood (2016) 128 (22): 5962.

https://doi.org/10.1182/blood.V128.22.5962.5962

Published: 2016

Journal Articles

Estimated Late Health Outcomes in Children Newly Diagnosed with Mature B-Cell Non-Hodgkin Lymphoma Treated with Contemporary LMB Chemotherapy Based upon Similarly Treated Participants in the Childhood Cancer Survivor Study (CCSS)

Matthew J. Ehrhardt, MD MS, Yan Chen, MMath, John Sandlund, MD, Elizabeth C. Bluhm, MD, Robert J. Hayashi, MD, Wendy M. Leisenring, ScD, Monika L. Metzger, MD, Kirsten K. Ness, PhD, Kevin R. Krull, PhD, Kevin C. Oeffinger, MD, Leslie L. Robison, PhD, Yutaka Yasui, PhD, Gregory T. Armstrong, MD MSCE, Melissa M. Hudson, MD, Daniel A. Mulrooney, MD

Blood (2016) 128 (22): 3609.

https://doi.org/10.1182/blood.V128.22.3609.3609

Published: 2016

Journal Articles

Economic Evaluation of Carfilzomib+Dexamethasone (Kd) Vs Bortezomib+Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (R/RMM)

Andrzej Jakubowiak, MD PhD, Istvan Matyas Majer, PhD, Ivan Houisse, MSc, Agnes Benedict, Marco Campioni, Sumeet Panjabi, Sikander Ailawadhi, MD

Blood (2016) 128 (22): 3582.

https://doi.org/10.1182/blood.V128.22.3582.3582

Published: 2016

Journal Articles

Increased Risk of Adverse Bone Health Outcomes in People with Bleeding Disorders

Jason Booth, MPH, Mei Lu, MS, Daniel Gallo, PhD, Diane Ito, MA, Leonard A. Valentino, MD FAAP

Blood (2016) 128 (22): 250.

https://doi.org/10.1182/blood.V128.22.250.250

Published: 2016

Journal Articles

Beta-Thalassemia Treatment and Complications in Two Large US Insured Population Databases

Nancy Maserejian, ScD, Li Li, MS, Jin Wang, MS, William E. Hobbs, MDPhD, Catherine Madigan, MD

Blood (2015) 126 (23): 3278.

https://doi.org/10.1182/blood.V126.23.3278.3278

Published: 2015

Journal Articles

Adult Transfusion-Dependent Thalassemia Patients in 2014: A Single Center Cross-Sectional Analysis of Health Outcomes

Ersilia M DeFilippis, BA, Patricia-Jane Giardina, MD, Dorothy Kleinert, NP, Maria Vogiatzi, MD, Paul Christos, DrPH, John C. Chapin, MD

Blood (2014) 124 (21): 4893.

https://doi.org/10.1182/blood.V124.21.4893.4893

Published: 2014

Journal Articles

A Novel Valuation Methodology for Patient-Derived Biological Assets with Case Study

Amrit Rau, Rajesh Behl, MD, Taher Abbasi, MS, Jeffrey L. Wolf

Blood (2014) 124 (21): 5998.

https://doi.org/10.1182/blood.V124.21.5998.5998

Published: 2014

Journal Articles

The Cost-Effectiveness of Clinical Genomic Tests to Aid CR1 Treatment Decisions in Intermediate-Risk AML

Sonya Cressman, PhD, Aly Karsan, MD, Donna E. Hogge, MD PhD, Emily McPherson, MSC, Stuart Peacock

Blood (2014) 124 (21): 2650.

https://doi.org/10.1182/blood.V124.21.2650.2650

Published: 2014

Journal Articles

Clinical trials have a home in Blood

Jorge Cortes, Nancy Berliner, Bob Löwenberg

Blood (2014) 123 (25): 3845–3846.

https://doi.org/10.1182/blood-2014-05-560698

Published: 2014

Journal Articles

Body Mass Index and Uncontrolled DM Impact On Acute Myeloid Leukemia (AML) Outcomes

Mohamed Abdelfatah, MD, Ankit Anand, MD, Zeyad Kanaan, MD, Ali Al-Ameri, MD, Nairmeen Haller, PhD

Blood (2013) 122 (21): 4998.

https://doi.org/10.1182/blood.V122.21.4998.4998

Published: 2013

Journal Articles

A Systematic Review Of All Interventional Sickle Cell Trials Registered At Clinicaltrials.Gov

Jeffrey D. Lebensburger, DO, Lauren Pair, Lee Hilliard, MD, Thomas H. Howard, MD

Blood (2013) 122 (21): 2990.

https://doi.org/10.1182/blood.V122.21.2990.2990

Published: 2013

Journal Articles

Health Outcomes in Vaso Occlusive Crisis of Sickle Cell Disease - Retrospective Indicators

Jigar Rajpura, Frank E. Shafer, MD, Krupa M. Sivamurthy, MBBS, MD, Carl Kollmer, Nicholas Vendetti, MS

Blood (2012) 120 (21): 4699.

https://doi.org/10.1182/blood.V120.21.4699.4699

Published: 2012

NARROW

Is It Time to Take MRD More Seriously? Relationship between MRD, Functional Cure and Life Expectancy Among Patients with Ph- B Cell Precursor ALL (BCP-ALL)

Nutrition Access in Adult Sickle Cell Patients: An Exploratory Study

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Comparison of Health Outcomes in Adolescent and Young Adults (AYA) Oncology Patients Treated at a Pediatric Versus Adult Institute

Clonal Hematopoiesis in Older Women with Extremely Skewed, Non-Random X-Inactivation Is Associated with Previous Cardiovascular and Cerebrovascular Events

CAR-T Therapy Displays Favorable Gains in Health Outcomes and Competitive Cost-Effectiveness When Compared with Past Innovative Cancer Treatments

Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada

Mortality Among California's Sickle Cell Data Collection Cohort, 2005-2015

Health-Related Quality of Life (HRQL) Among Hospitalized Adults with Sickle Cell Disease (SCD): Incorporating Patient-Reported Outcome (PRO) Measures in Clinical Care

Estimated Late Health Outcomes in Children Newly Diagnosed with Mature B-Cell Non-Hodgkin Lymphoma Treated with Contemporary LMB Chemotherapy Based upon Similarly Treated Participants in the Childhood Cancer Survivor Study (CCSS)

Economic Evaluation of Carfilzomib+Dexamethasone (Kd) Vs Bortezomib+Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (R/RMM)

Increased Risk of Adverse Bone Health Outcomes in People with Bleeding Disorders

Beta-Thalassemia Treatment and Complications in Two Large US Insured Population Databases

Adult Transfusion-Dependent Thalassemia Patients in 2014: A Single Center Cross-Sectional Analysis of Health Outcomes

A Novel Valuation Methodology for Patient-Derived Biological Assets with Case Study

The Cost-Effectiveness of Clinical Genomic Tests to Aid CR1 Treatment Decisions in Intermediate-Risk AML

Clinical trials have a home in Blood

Body Mass Index and Uncontrolled DM Impact On Acute Myeloid Leukemia (AML) Outcomes

A Systematic Review Of All Interventional Sickle Cell Trials Registered At Clinicaltrials.Gov

Health Outcomes in Vaso Occlusive Crisis of Sickle Cell Disease - Retrospective Indicators

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only